T. Cerny

Prophylaxis and reversal of ifosfamide encephalopathy with methylene-blue

A Küpfer, C. Aeschlimann, B. Wermuth et al. · The Lancet · 1994 · 179 citations

Cerebrospinal Fluid, Clinical Pharmacology, Toxicology +4

Methylene blue and the neurotoxic mechanisms of ifosfamide encephalopathy

A Küpfer, C. Aeschlimann, T. Cerny · European Journal of Clinical Pharmacology · 1996 · 108 citations

Medicine, Methylene Blue, Neuropharmacology +6

Assessment of P-glycoprotein, glutathione-based detoxifying enzymes and O6-alkylguanine-DNA alkyltransferase as potential indicators of constitutive drug resistance in human colorectal tumors.

Shelagh Redmond, Franziska Joncourt, K Buser et al. · PubMed · 1991 · 87 citations

Constitutive Drug Resistance, Tumor Biology, Health Sciences +14

Prolongation of ifosfamide elimination half-life in obese patients due to altered drug distribution

Michael Lind, J. Margison, T. Cerny et al. · Cancer Chemotherapy and Pharmacology · 1989 · 66 citations

Obesity, Metabolic Syndrome, Bariatric Surgery +9

Elevated preoperative CEA is associated with worse survival in stage I–III rectal cancer patients

Ignazio Tarantino, René Warschkow, Mathias Worni et al. · British Journal of Cancer · 2012 · 66 citations · Full text